Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder that affects the nerve cells in the brain and spinal cord. ALS primarily impacts the motor neurons, which are responsible for controlling voluntary muscles throughout the body. As the disease progresses, these motor neurons degenerate and die, leading to a gradual loss of muscle function and control.
Individuals with ALS may experience symptoms such as muscle weakness, twitching, and stiffness. As the condition advances, it can lead to difficulties in speaking, swallowing, and ultimately breathing. The exact cause of ALS is not fully understood, and it can affect people of any age, though it is more commonly diagnosed in individuals between the ages of 40 and 70.
ALS is a relentlessly progressive condition, and unfortunately, there is currently no cure for this disease. Treatment usually focuses on managing symptoms, enhancing the quality of life, and providing support for individuals and their families. The progression of Amyotrophic Lateral Sclerosis (ALS) varies from person to person, with some individuals experiencing a more rapid decline than others. Research efforts are ongoing to better understand the underlying causes of ALS and to develop potential treatments to slow down or halt its progression.